SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-18-006584
Filing Date
2018-05-10
Accepted
2018-05-10 17:23:09
Documents
53
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 843339
2 ex31-1.htm EX-31.1 16632
3 ex32-1.htm EX-32.1 8668
  Complete submission text file 0001493152-18-006584.txt   6422648

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE FILE ppcb-20180331.xml EX-101.INS 780734
5 XBRL SCHEMA FILE ppcb-20180331.xsd EX-101.SCH 68191
6 XBRL CALCULATION FILE ppcb-20180331_cal.xml EX-101.CAL 53099
7 XBRL DEFINITION FILE ppcb-20180331_def.xml EX-101.DEF 223879
8 XBRL LABEL FILE ppcb-20180331_lab.xml EX-101.LAB 412018
9 XBRL PRESENTATION FILE ppcb-20180331_pre.xml EX-101.PRE 284095
Mailing Address 302/6 BUTLER STREET CAMBERWELL, VICTORIA C3 3124
Business Address 302/6 BUTLER STREET CAMBERWELL, VICTORIA C3 3124 613-9882-6723
Propanc Biopharma, Inc. (Filer) CIK: 0001517681 (see all company filings)

IRS No.: 300662986 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-54878 | Film No.: 18824109
SIC: 2834 Pharmaceutical Preparations